Missed Out on Novo Nordisk? This Much Smaller Danish Biotech Could Be the Next Hot Weight-Loss Stock.

A big focus for healthcare companies recently has been on the weight-loss industry. It's no coincidence that two of the most valuable healthcare stocks in the world are big players in that field with a couple of promising weight-loss treatments.Companies are eager to get glucagon-like peptide 1 (GLP-1) drugs to market because they could help bolster their long-term growth prospects. And investors are paying attention, as possessing the next big weight-loss drug could be a sign of a stock that's due to skyro ...